Racial Disparities in Treatments and Mortality among a Large Population-Based Cohort of Older Men and Women With Colorectal Cancer

BACKGROUND: There were racial disparities in treatment and mortality among patients with colorectal cancer, but few studies incorporated information on hypertension and diabetes and their treatment status. PATIENTS AND METHODS: The study identified 101,250 patients from Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database in the United States who were diagnosed with colorectal cancer at age ≥65 years between 2007 and 2015 with follow-up to December 2016. RESULTS: There were substantial racial and ethnic disparities in the prevalence of hypertension and diabetes in patients with colorectal cancer, in receiving chemotherapy and radiation therapy, and in receiving antihypertensive and antidiabetic treatment. Racial disparities in receiving these therapies remained significant in this large cohort of Medicare beneficiaries after stratifications by private health insurance status at the time of cancer diagnosis and by tumor stage. Non-Hispanic black patients had a significantly higher risk of all-cause mortality (hazard ratio: 1.07, 95% CI: 1.04-1.10), which remained significantly higher (1.05, 1.02-1.08) after adjusting for patient sociodemographics, tumor factors, comorbidity and treatments as compared to non-Hispanic white patients. The adjusted risk of colorectal cancer-specific mortality was also significantly higher (1.08, 1.04-1.12) between black and white patients. CONCLUSIONS: There were substantial racial disparities in prevalence of hypertension and diabetes in men and women diagnosed with colorectal cancer and in receipt of chemotherapy, radiation therapy, antihypertensive and antidiabetic treatment. Black patients with colorectal cancer had a significantly higher risk of all-cause mortality and colorectal cancer-specific mortality than whites, even after adjusting for sociodemographic characteristics, tumor factors, comorbidity scores, and treatments

Corrosion-induced deterioration and fracture mechanisms in ultra-high-performance fiber-reinforced concretet

Ultra-high-performance fiber-reinforced concrete (UHPFRC) is an excellent material for harsh environments, but corrosion will change its internal microstructure and complicate the fracture evolution, bringing great difficulties in evaluating the long-term service life. Limited attention has been paid to the fracture mechanism of the UHPFRC upon corrosion. In the present study, integrating acoustic emission (AE) and digital image correlation (DIC) techniques are used to assess the micro/macrocracking characteristics of the specimens upon various corrosion degrees. Results show that the 56-day corroded UHPFRC with 2 vol% presents a remarkable decrease rate of 32%, 29% and 30% in the flexural stiffness, flexural strength and compressive strength. During the loading process, compaction of the original defects induced by fiber corrosion is concentrated in the elastic stage, the newborn cracks triggered by loading mainly occur in the strain-hardening stage, and the expansion of cracks mainly lies in the strain-softening stage. Corroded UHPFRC specimens with higher corrosion damage have a greater maximum strain value at the crack. In addition, the failure mode changes from shear crack failure to a brittle failure of tensile crack as corrosion damage increases. The macroscopic destruction of the corroded UHPFRC is a manifestation of internal microdamage evolution in fiber corrosion and matrix deterioration.</p

Associations Between Vascular Diseases and alzheimer\u27s Disease or Related Dementias in a Large Cohort of Men and Women With Colorectal Cancer

BACKGROUND: Long term risk of Alzheimer\u27s disease (AD) and related dementias (ADRD) associated with vascular diseases in people with colorectal cancer is unknown. OBJECTIVE: to determine the risk of ADRD in association with cardiovascular diseases (CVD), stroke, hypertension, and diabetes in a cohort of patients with colorectal cancer. METHODS: This retrospective cohort study consisted of 210,809 patients diagnosed with colorectal cancer at age≥65 years in 1991-2015 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database with follow-up from 1991-2016, who were free of any ADRD at the baseline (\u3c 30 days after the date of cancer diagnosis). RESULTS: The crude 26-year cumulative incidence of total ADRD in men and women with colorectal cancer was higher in those with versus without CVD (31.92% versus 28.12%), with versus without stroke (39.82% versus 26.39%), with versus without hypertension (31.88% versus 24.88%), and with versus without diabetes (32.01% versus 27.66%). After adjusting for socio-demographic and tumor factors, the risk of developing ADRD was significantly higher in patients with CVD (adjusted hazard ratio: 1.17, 95% confidence intervals: 1.14-1.20), stroke (1.65, 1.62-1.68), hypertension (1.07, 1.05-1.09), and diabetes (1.26, 1.24-1.29) versus persons without. For those with 1, 2, 3 and 4 vascular diseases present versus absent, the risk of AD increased from 1.12 (1.07-1.16) to 1.31 (1.25-1.36), 1.66 (1.57-1.75), and 2.03 (1.82-2.27). CONCLUSION: In older patients with colorectal cancer, a significant dose-response relationship was observed between an increasing number of these vascular diseases and the risk of all types of dementia

Risk of Developing alzheimer\u27s Disease and Related Dementias in association With Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women With Breast Cancer and With Up to 26 Years of Follow-Up

BACKGROUND: No study on the long-term incidence of Alzheimer\u27s disease (AD) and related dementias (ADRD) has been reported in women with breast cancer by vascular diseases. OBJECTIVE: to determine the risk of ADRD in association with cardiovascular diseases (CVD), stroke, hypertension, and diabetes in women with breast cancer. METHODS: Study identified 246,686 women diagnosed with breast cancer at age≥65 years in 1991-2015 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Women were free of ADRD at the time of cancer diagnosis and followed from 1991 to 2016. RESULTS: Cumulative incidence of AD over 26 years of follow-up varied from 10.7% to 13.6% by CVD, stroke, hypertension, and diabetes. Cumulative incidence of ADRD was higher in those with CVD (40.75%) versus no-CVD (31.32%), stroke (40.24%) versus no-stroke (31.34%), hypertension (33.06%) versus no-hypertension (30.47%), and diabetes (33.38%) versus no-diabetes (31.77%). After adjusting for confounders, those with CVD (hazard ratio:1.30, 95% CI: 1.27-1.33), stroke (1.50,1.47-1.54), hypertension (1.08,1.06-1.09), and diabetes (1.26,1.24-1.29) had significantly higher risks of developing ADRD. Women aged 80-84, and≥85 had 5- and 7-fold higher risks of AD than those aged 65-69. As compared to white women, black women had a significantly higher risk of AD (1.21, 1.16-1.27), whereas Asians/Pacific-Islanders had a significantly lower risk of AD (0.77, 0.71-0.83). CONCLUSION: In women with breast cancer, CVD, stroke, hypertension, and diabetes were associated with a significantly higher risk of developing any ADRD combined. The risk of ADRD was higher in black women and lower in Asian/Pacific-Islanders than white women

Simple Synthesis and Enhanced Performance of Graphene Oxide-Gold Composites

Graphene oxide-gold composites were prepared by one-step reaction in aqueous solution, where the gold nanoparticles were deposited on the graphene oxide during their synthesis process. Transmission electron morphology, X-ray diffraction, Roman spectra, and UV-Vis absorption spectra were used to characterize the obtained composites. Furthermore, based on the BET analysis results, it was found that the surface area of the composite film was obviously enhanced compared with the synthesized graphene oxide. Electrochemical measurements indicated that the modification of the composites on electrode could efficiently enhance the voltammetric response, suggesting the potential application for making electrochemical sensors

A novel method for purifying bluetongue virus with high purity by co-immunoprecipitation with agarose protein A

<p>Abstract</p> <p>Background</p> <p>Bluetongue virus (BTV) is an icosahedral non-enveloped virus within the genus <it>Orbivirus </it>of <it>Reoviridae </it>and exists as 24 distinct serotypes. BTV can infect all ruminant species and causes severe sickness in sheep. Recently, it was reported that BTV can infect some human cancer cells selectively. Because of the important oncolysis of this virus, we developed a novel purifying method for large-scale production. The purifying logic is simple, which is picking out all the components unwanted and the left is what we want. The process can be summarized in 4 steps: centrifugation, pulling down cell debrises and soluble proteins by co-immunoprecipitation with agarose Protein A, dialysis and filtration sterilization after concentration.</p> <p>Results</p> <p>The result of transmission electron microscope (TEM) observation showed that the sample of purified virus has a very clear background and the virions still kept intact. The result of 50% tissue culture infective dose (TCID₅₀) assay showed that the bioactivity of purified virus is relatively high.</p> <p>Conclusions</p> <p>This method can purify BTV-10 with high quality and high biological activity on large-scale production. It also can be used for purifying other BTV serotypes.</p